When posterior malleolus fractures occur with syndesmotic injury, anatomic fracture reduction and fixation are paramount as they can affect syndesmotic reduction, especially with larger fragments.
This study compared the postoperative analgesic efficacy of liposomal bupivacaine as a single-administration adductor canal block (ACB) vs periarticular injection (PAI) for pain control after total knee arthroplasty (TKA). From May 2016 to June 2017, a total of 70 unilateral TKA patients were randomized into 2 groups: PAI (extended-release bupivacaine 266 mg [20-mL vial] with 20 mL of 0.5% bupivacaine hydrochloride and normal saline to a total volume of 120 mL) and ACB (subsartorial saphenous nerve using extended-release bupivacaine 266 mg [20-mL vial]). All patents underwent spinal anesthesia with comprehensive preemptive and postoperative multi-modal pain protocol. All opioids administered were converted to morphine equivalents. Pain was recorded at 4 to 12 hours on the day of surgery, and on postoperative days 1, 2, and 3. Patients and investigators other than the surgeon and anesthesiologist were blinded to the study. The difference in pain scores between the PAI and ACB groups was not statistically significant during the first 12 hours (day 0) after surgery or on postoperative day 1 (5.31 vs 4.26, P =.091). However, on postoperative day 3, the mean pain score increased in the ACB group and decreased in the PAI group (4.8 vs 1.83, P =.037). There was no statistically significant difference between the 2 groups regarding the accumulative daily converted morphine equivalent consumption or total consumption. Although the PAI group demonstrated longer lasting pain relief than the ACB group for the duration of the study, other outcomes were similar between the 2 groups. [ Orthopedics . 2020; 43(1):e47–e53.]
Background: Computer-assisted navigation has the potential to improve the accuracy of cup positioning during total hip arthroplasty (THA) and prevent leg-length discrepancy (LLD). The purpose of this study was to compare acetabular cup position and postoperative LLD after primary THA using posterolateral approach. Methods: Between August 2016 to December 2017, 57 THAs using imageless navigation were matched with 57 THA without navigation, based on age, gender, and BMI. Postoperative weight-bearing radiographs were assessed for anteversion, inclination, and LLD. Functional LLD was measured in comparison to the contralateral side. The proportion of cups within Lewinnek’s safe zone and LLD greater than 5 mm were assessed. Results: The mean age was 54.9±9.6 yr and 57.6±12.5 yr in control and navigated groups, respectively. Mean cup orientation in the navigated group was 20.6±3.3 degrees (17 to 25) of anteversion and 41.9±4.8 degrees (30 to 51) of inclination, versus 25±11.1 degrees (10 to 31) and 45.7±8.7 degrees (29 to 55) in the control group; these were statistically significant (P=0.005 and P<0.001, respectively). In the navigated group, significantly more acetabular cups were placed within Lewinnek’s safe zone (anteversion: 77% vs. 47%, P=0.005; inclination: 91% vs. 67%, P<0.001). There was no significant difference in mean LLD in the navigation and control groups (3.2±1.5 mm vs. 4.6±3.4 mm, P=0.36), although fewer LLDs of greater than 5 mm were reported in the navigated group (7.1%) than in the control group (31.6%, P=0.007). Conclusions: The use of imageless computer-assisted navigation improved the accuracy of acetabular cup components and LLD. Level of Evidence: Level III.
This operative approach may be appropriate for early stages plantar plate tear when only lateral soft tissue repair is needed. This technique should not preclude conversion to a more extensile operative approach or an additional metatarsal osteotomy if needed. Applicability of this operative approach in cases with more advanced pathologies or involving only medial soft tissue structures requires further studies.
Orthopedic implant device sales representatives (“reps”) can provide intraoperative guidance based on their product knowledge, as part of their many responsibilities. However, for experienced high-volume arthroplasty surgeons, a representative may not be required in the room for most primary total knee arthroplasty (TKA) procedures. The goal of this study was to describe the authors' experience with a modified rep model for primary TKA. Between January and December 2017, a total of 100 unilateral primary TKAs were performed with a modified rep model and compared with 100 primary TKAs that were performed before this protocol. The authors adopted 2 additional initiatives to institute this protocol safely: (1) improved education of operating room staff and allocation of responsibilities; and (2) reengineering of the existing surgical trays. No perioperative complications, including readmission, periprosthetic fracture, or infection, occurred in either group. In addition, no difference was found in mean length of stay between the modified rep and conventional cohorts (2.2 and 2.4 days, respectively; P =.49). Mean operating room time was less with the modified rep cohort (102.1 vs 117.8 minutes; P <.001), as was total instrument turnover time in the operating room (13.9 vs 29.7 minutes; P <.0001) and in central sterilization (59.4 vs 126.8 minutes; P <.001). No errors occurred with implant accuracy or trays, and there was no need to change the type of implant with the modified rep model, compared with 6% of trays requiring additional sterilization with the conventional model. The negotiated implant cost with the modified rep model was approximately $2000 less than that for the conventional group. This study found that the modified rep model for primary TKA is safe and has the potential for substantial cost savings. [ Orthopedics . 2020;43(6):e538–e542.]
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.